Vor Biopharma Inc (VOR) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $15.90
• Market Cap: $666.81M
• EPS: $-386.86
• 52-Week High: $65.80
• 52-Week Low: $2.62

Market Sentiment

Vor Biopharma Inc currently has a Bullish sentiment score of 0.34.

About Vor Biopharma Inc

Vor Biopharma Inc. is a cutting-edge biopharmaceutical company headquartered in Cambridge, Massachusetts, dedicated to developing innovative hematopoietic stem cell (eHSC) therapies for cancer treatment. Utilizing proprietary technology platforms, the company strives to create targeted therapies that significantly improve patient outcomes, including durable responses and overall survival. Vor's focus on advancing cell therapies places it at the vanguard of the dynamic oncology market, present...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Vor Biopharma Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does VOR pay dividends?

Vor Biopharma Inc (VOR) does not currently pay a regular dividend.

What is VOR's market cap?

Vor Biopharma Inc (VOR) has a market capitalization of $666.81M with a current stock price of $15.90.